♥
ISIN : INE882C01035
BSE : 511523
Face Value : 10
Industry : Finance - Investment
EPS : 0.21
EPS (TTM) : 0.08
Price to Earning (P/E) : 96.71
Book Value : 10.92
Price to Bookvalue (P/B) : 1.86
Dividend Yield : 0 %
Return on Equity (ROE) : 1.88 %
Return on Capital Employed (ROCE) : 5.96 %
Veerhealth Care Limited
ISIN : INE882C01035
BSE : 511523
Face Value : 10
Industry : Finance - Investment
EPS : 0.21
EPS (TTM) : 0.08
Price to Earning (P/E) : 96.71
Book Value : 10.92
Price to Bookvalue (P/B) : 1.86
Dividend Yield : 0 %
Return on Equity (ROE) : 1.88 %
Return on Capital Employed (ROCE) : 5.96 %
Veerhealth Care share price(02-Apr-2026) | |
|---|---|
| Open / Close | 20.45 - 20.31 -0.7 % |
| Low / High | 20.03 - 20.45 2.1 % |
| Trade Volume | 30,538 |
| 52 Week Low / High | 12.69 - 23.77 87.3 % |
-
YOU MAY ALSO LIKE
- Share Market basics for beginners
Share Market jargons in simple terms - Stock market course tutorial
Stock Market Investment Course explained in simple words. - How much money do you need to retire
Know how much money do you need to retire, before how much to invest ? - High dividend stocks
High dividend yield stocks on Stock exchange NSE and BSE - Low PE ratio stocks
Undervalued, low PE ratio stocks on Stock exchange NSE and BSE - CAGR Calculator
Check your investment returns using our CAGR / Investment Growth Calculator
CONSOLIDATED QUARTERLY RESULT FOR VEERHEALTH CARE LIMITED
| Date End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 20.14 | 28.56 | 39.28 | 27.54 | 37.34 | 35.81 | 38.28 | 28.69 | 33.67 | 20.64 |
| Total Income | 26.41 | 29.06 | 43.44 | 31.06 | 40.09 | 37.26 | 42.43 | 31.1 | 35.33 | 24.23 |
| Total Expenditure | 25.5 | 26.51 | 39.99 | 25.91 | 33.59 | 31.48 | 36.13 | 26.91 | 31.92 | 20.78 |
| Other Income | 6.27 | 0.5 | 4.15 | 3.52 | 2.75 | 1.45 | 4.15 | 2.41 | 1.66 | 3.58 |
| Operating Profit | 0.91 | 2.55 | 3.45 | 5.15 | 6.5 | 5.78 | 6.3 | 4.19 | 3.41 | 3.45 |
| Interest | 0.01 | 0.01 | 0.02 | 0.04 | 0.02 | 0.02 | ||||
| Exceptional Items | -0.02 | |||||||||
| PBDT | 0.9 | 2.55 | 3.45 | 5.14 | 6.5 | 5.78 | 6.28 | 4.13 | 3.39 | 3.43 |
| Depreciation | 1.34 | 1.47 | 1.54 | 1.58 | 1.62 | 1.75 | 1.76 | 1.79 | 1.81 | 1.91 |
| Profit Before Tax | -0.44 | 1.08 | 1.91 | 3.56 | 4.88 | 4.03 | 4.52 | 2.34 | 1.58 | 1.52 |
| Tax | 3.04 | 0.15 | 0.54 | 0.27 | -5.57 | 0.6 | 0.6 | 0.44 | 7.12 | 0.3 |
| Profit After Tax | -3.48 | 0.93 | 1.37 | 3.29 | 10.45 | 3.43 | 3.92 | 1.9 | -5.54 | 1.22 |
| Net Profit | -3.48 | 0.93 | 1.37 | 3.29 | 10.45 | 3.43 | 3.92 | 1.9 | -5.54 | 1.22 |
| Equity Capital | 69.34 | 69.34 | 69.34 | 69.34 | 99.99 | 99.99 | 199.98 | 199.98 | 199.98 | 199.98 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | -0.5 | 0.13 | 0.2 | 0.47 | 1.05 | 0.34 | 0.2 | 0.1 | -0.28 | 0.06 |
| Diluted Eps After Extraordinary Items | -0.5 | 0.12 | 0.19 | 0.46 | 1.01 | 0.33 | 0.19 | 0.09 | -0.26 | 0.06 |
| Diluted Eps Before Extraordinary Items | -0.5 | 0.12 | 0.19 | 0.46 | 1.01 | 0.33 | 0.19 | 0.09 | -0.26 | 0.06 |
STANDALONE QUARTERLY RESULT FOR VEERHEALTH CARE LIMITED
| Date End | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| No of months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months | 3 months |
| Net Sales | 20.14 | 28.56 | 39.28 | 27.54 | 37.34 | 35.81 | 38.28 | 28.69 | 33.67 | 20.64 |
| Total Income | 26.41 | 29.06 | 43.44 | 31.06 | 40.09 | 37.26 | 42.43 | 31.1 | 35.33 | 24.23 |
| Total Expenditure | 25.5 | 26.51 | 39.99 | 25.91 | 33.59 | 31.48 | 36.13 | 26.91 | 31.92 | 20.78 |
| Other Income | 6.27 | 0.5 | 4.15 | 3.52 | 2.75 | 1.45 | 4.15 | 2.41 | 1.66 | 3.58 |
| Operating Profit | 0.91 | 2.55 | 3.45 | 5.15 | 6.5 | 5.78 | 6.3 | 4.19 | 3.41 | 3.45 |
| Interest | 0.01 | 0.01 | 0.02 | 0.04 | 0.02 | 0.02 | ||||
| Exceptional Items | -0.02 | |||||||||
| PBDT | 0.9 | 2.55 | 3.45 | 5.14 | 6.5 | 5.78 | 6.28 | 4.13 | 3.39 | 3.43 |
| Depreciation | 1.34 | 1.47 | 1.54 | 1.58 | 1.62 | 1.75 | 1.76 | 1.79 | 1.81 | 1.91 |
| Profit Before Tax | -0.44 | 1.08 | 1.91 | 3.56 | 4.88 | 4.03 | 4.52 | 2.34 | 1.58 | 1.52 |
| Tax | 3.04 | 0.15 | 0.54 | 0.27 | -5.57 | 0.6 | 0.6 | 0.44 | 7.12 | 0.3 |
| Profit After Tax | -3.48 | 0.93 | 1.37 | 3.29 | 10.45 | 3.43 | 3.92 | 1.9 | -5.54 | 1.22 |
| Net Profit | -3.48 | 0.93 | 1.37 | 3.29 | 10.45 | 3.43 | 3.92 | 1.9 | -5.54 | 1.22 |
| Equity Capital | 69.34 | 69.34 | 69.34 | 69.34 | 99.99 | 99.99 | 199.98 | 199.98 | 199.98 | 199.98 |
| Face Value (IN RS) | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
| Calculated EPS | -0.5 | 0.13 | 0.2 | 0.47 | 1.05 | 0.34 | 0.2 | 0.1 | -0.28 | 0.06 |
| Diluted Eps After Extraordinary Items | -0.5 | 0.12 | 0.19 | 0.46 | 1.01 | 0.33 | 0.19 | 0.09 | -0.26 | 0.06 |
| Diluted Eps Before Extraordinary Items | -0.5 | 0.12 | 0.19 | 0.46 | 1.01 | 0.33 | 0.19 | 0.09 | -0.26 | 0.06 |
CONSOLIDATED ANNUAL RESULT FOR VEERHEALTH CARE LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 96.26 | 132.73 | 132.23 |
| Total Income | 112.94 | 145.13 | 146.13 |
| Total Expenditure | 104.47 | 127.73 | 126.11 |
| Other Income | 16.67 | 12.39 | 13.9 |
| Operating Profit | 8.47 | 17.4 | 20.02 |
| Interest | 0.85 | 0.01 | 0.08 |
| Exceptional Items | -0.02 | ||
| PBDT | 7.62 | 17.39 | 19.92 |
| Depreciation | 5.24 | 6.22 | 7.12 |
| Profit Before Tax | 2.38 | 11.17 | 12.8 |
| Tax | 3.34 | -4.66 | 8.75 |
| Profit After Tax | -0.96 | 15.83 | 4.05 |
| Net Profit | -0.96 | 15.83 | 4.05 |
| Equity Capital | 69.34 | 99.99 | 199.98 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 70.15 | 114.33 | 18.4 |
| Calculated EPS | -0.14 | 1.58 | 0.2 |
| Diluted Eps After Extraordinary Items | -0.14 | 1.52 | 0.21 |
| Diluted Eps Before Extraordinary Items | -0.14 | 1.52 | 0.21 |
STANDALONE ANNUAL RESULT FOR VEERHEALTH CARE LIMITED
| Date End | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|
| No of months | 12 months | 12 months | 12 months |
| Net Sales | 96.26 | 132.73 | 132.23 |
| Total Income | 112.94 | 145.13 | 146.13 |
| Total Expenditure | 104.47 | 127.73 | 126.11 |
| Other Income | 16.67 | 12.39 | 13.9 |
| Operating Profit | 8.47 | 17.4 | 20.02 |
| Interest | 0.85 | 0.01 | 0.08 |
| Exceptional Items | -0.02 | ||
| PBDT | 7.62 | 17.39 | 19.92 |
| Depreciation | 5.24 | 6.22 | 7.12 |
| Profit Before Tax | 2.38 | 11.17 | 12.8 |
| Tax | 3.34 | -4.66 | 8.75 |
| Profit After Tax | -0.96 | 15.83 | 4.05 |
| Net Profit | -0.96 | 15.83 | 4.05 |
| Equity Capital | 69.34 | 99.99 | 199.98 |
| Face Value (IN RS) | 10 | 10 | 10 |
| Reserves | 70.15 | 114.33 | 18.4 |
| Calculated EPS | -0.14 | 1.58 | 0.2 |
| Diluted Eps After Extraordinary Items | -0.14 | 1.52 | 0.21 |
| Diluted Eps Before Extraordinary Items | -0.14 | 1.52 | 0.21 |
CONSOLIDATED PROFIT / LOSS FOR VEERHEALTH CARE LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Operating Income | 10.58 Cr | 9.63 Cr | 13.27 Cr | 13.22 Cr |
| Processing fees and other charges | 90.52 Lk | 1.36 Cr | 0 | 0 |
| Operating Income (Net) | 10.58 Cr | 9.63 Cr | 13.27 Cr | 13.22 Cr |
| Increase/Decrease in Stock | -43.27 Lk | -46.1 Lk | -48.17 Lk | 1.21 Cr |
| Employee Cost | 82.76 Lk | 87.77 Lk | 90.19 Lk | 1.31 Cr |
| Salaries, Wages & Bonus | 78.79 Lk | 84.1 Lk | 87.35 Lk | 1.28 Cr |
| Contributions to EPF & Pension Funds | 41,000 | 13,000 | 57,000 | 83,000 |
| Workmen and Staff Welfare Expenses | 3.56 Lk | 3.54 Lk | 2.27 Lk | 2.3 Lk |
| Operating & Establishment Expenses | 1.37 Cr | 1 Cr | 40.86 Lk | 22.05 Lk |
| Commission, Brokerage & Discounts | 41,000 | 3.84 Lk | 7,000 | 43,000 |
| Rent , Rates & Taxes | 40,000 | 96,000 | 6.09 Lk | 2.57 Lk |
| Repairs and Maintenance | 15.06 Lk | 20.44 Lk | 24.52 Lk | 12.74 Lk |
| Insurance | 2.65 Lk | 1.96 Lk | 2.25 Lk | 2.28 Lk |
| Electricity & Power | 25.34 Lk | 20.2 Lk | 11.32 Lk | 15.56 Lk |
| Administrations & Other Expenses | 86.94 Lk | 1.33 Cr | 59.22 Lk | 60.64 Lk |
| Printing and stationery | 39,000 | 1.79 Lk | 2.21 Lk | 1.84 Lk |
| Professional and legal fees | 14.38 Lk | 26.1 Lk | 33.18 Lk | 38.3 Lk |
| Advertisement & Sales Promotion | 7.02 Lk | 29.15 Lk | 36.73 Lk | 22.79 Lk |
| Provisions and Contingencies | 6.08 Lk | 32.21 Lk | 34.72 Lk | 39.74 Lk |
| Loss on disposal of fixed assets(net) | 0 | 0 | 27,000 | 16,000 |
| Total Expenditure | 10.64 Cr | 10.46 Cr | 12.78 Cr | 12.61 Cr |
| Other Income | 1.33 Cr | 1.68 Cr | 1.25 Cr | 1.39 Cr |
| Other Interest Income | 40.66 Lk | 49.42 Lk | 0 | 0 |
| Discounts | 3.64 Lk | 91,000 | 96,000 | 0 |
| Operating Profit | 1.26 Cr | 84.69 Lk | 1.74 Cr | 2 Cr |
| Interest | 21.85 Lk | 8.51 Lk | 13,000 | 76,000 |
| Depreciation | 46.82 Lk | 52.42 Lk | 62.18 Lk | 71.15 Lk |
| Profit Before Taxation & Exceptional Items | 57.66 Lk | 23.76 Lk | 1.12 Cr | 1.28 Cr |
| Profit Before Tax | 57.66 Lk | 23.76 Lk | 1.12 Cr | 1.28 Cr |
| Provision for Tax | 19.74 Lk | 31.12 Lk | -46.51 Lk | 87.53 Lk |
| Current Income Tax | 9.49 Lk | 3.75 Lk | 19.65 Lk | 28.5 Lk |
| Deferred Tax | 4.63 Lk | 27.37 Lk | -66.16 Lk | 59.03 Lk |
| Profit After Tax | 37.92 Lk | -7.36 Lk | 1.58 Cr | 40.61 Lk |
| Other Consolidated Items | 0 | 0 | -6.52 Lk | 76,000 |
| Consolidated Net Profit | 37.92 Lk | -7.36 Lk | 1.52 Cr | 41.37 Lk |
| Profit Balance B/F | 20.5 Lk | 50.55 Lk | 43.19 Lk | 1.95 Cr |
| Appropriations | 58.42 Lk | 43.19 Lk | 1.95 Cr | 2.36 Cr |
| Earnings Per Share | 0.55 | -0.11 | 1.58 | 0.2 |
| Adjusted EPS | 0.55 | -0.11 | 1.58 | 0.2 |
STANDALONE PROFIT / LOSS FOR VEERHEALTH CARE LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Operating Income | 10.58 Cr | 9.63 Cr | 13.27 Cr | 13.22 Cr |
| Processing fees and other charges | 90.52 Lk | 1.36 Cr | 0 | 0 |
| Operating Income (Net) | 10.58 Cr | 9.63 Cr | 13.27 Cr | 13.22 Cr |
| Increase/Decrease in Stock | -43.27 Lk | -46.1 Lk | -48.17 Lk | 1.21 Cr |
| Employee Cost | 82.76 Lk | 87.77 Lk | 90.19 Lk | 1.31 Cr |
| Salaries, Wages & Bonus | 78.79 Lk | 84.1 Lk | 87.35 Lk | 1.28 Cr |
| Contributions to EPF & Pension Funds | 41,000 | 13,000 | 57,000 | 83,000 |
| Workmen and Staff Welfare Expenses | 3.56 Lk | 3.54 Lk | 2.27 Lk | 2.3 Lk |
| Operating & Establishment Expenses | 1.37 Cr | 1 Cr | 40.86 Lk | 22.05 Lk |
| Commission, Brokerage & Discounts | 41,000 | 3.84 Lk | 7,000 | 43,000 |
| Rent , Rates & Taxes | 40,000 | 96,000 | 6.09 Lk | 2.57 Lk |
| Repairs and Maintenance | 15.06 Lk | 20.44 Lk | 24.52 Lk | 12.74 Lk |
| Insurance | 2.65 Lk | 1.96 Lk | 2.25 Lk | 2.28 Lk |
| Electricity & Power | 25.34 Lk | 20.2 Lk | 11.32 Lk | 15.56 Lk |
| Administrations & Other Expenses | 86.94 Lk | 1.33 Cr | 59.22 Lk | 60.64 Lk |
| Printing and stationery | 39,000 | 1.79 Lk | 2.21 Lk | 1.84 Lk |
| Professional and legal fees | 14.38 Lk | 26.1 Lk | 33.18 Lk | 38.3 Lk |
| Advertisement & Sales Promotion | 7.02 Lk | 29.15 Lk | 36.73 Lk | 22.79 Lk |
| Provisions and Contingencies | 6.08 Lk | 32.21 Lk | 34.72 Lk | 39.74 Lk |
| Loss on disposal of fixed assets(net) | 0 | 0 | 27,000 | 16,000 |
| Total Expenditure | 10.64 Cr | 10.46 Cr | 12.78 Cr | 12.61 Cr |
| Other Income | 1.33 Cr | 1.68 Cr | 1.25 Cr | 1.39 Cr |
| Other Interest Income | 40.66 Lk | 49.42 Lk | 0 | 0 |
| Discounts | 3.64 Lk | 91,000 | 96,000 | 0 |
| Operating Profit | 1.26 Cr | 84.69 Lk | 1.74 Cr | 2 Cr |
| Interest | 21.85 Lk | 8.51 Lk | 13,000 | 76,000 |
| Depreciation | 46.82 Lk | 52.42 Lk | 62.18 Lk | 71.15 Lk |
| Profit Before Taxation & Exceptional Items | 57.66 Lk | 23.76 Lk | 1.12 Cr | 1.28 Cr |
| Profit Before Tax | 57.66 Lk | 23.76 Lk | 1.12 Cr | 1.28 Cr |
| Provision for Tax | 19.74 Lk | 31.12 Lk | -46.51 Lk | 87.53 Lk |
| Current Income Tax | 9.49 Lk | 3.75 Lk | 19.65 Lk | 28.5 Lk |
| Deferred Tax | 4.63 Lk | 27.37 Lk | -66.16 Lk | 59.03 Lk |
| Profit After Tax | 37.92 Lk | -7.36 Lk | 1.58 Cr | 40.61 Lk |
| Other Consolidated Items | 0 | 0 | -6.52 Lk | 76,000 |
| Consolidated Net Profit | 37.92 Lk | -7.36 Lk | 1.52 Cr | 41.37 Lk |
| Profit Balance B/F | 20.5 Lk | 50.55 Lk | 43.19 Lk | 1.95 Cr |
| Appropriations | 58.42 Lk | 43.19 Lk | 1.95 Cr | 2.36 Cr |
| Earnings Per Share | 0.55 | -0.11 | 1.58 | 0.2 |
| Adjusted EPS | 0.55 | -0.11 | 1.58 | 0.2 |
CONSOLIDATED CASH FLOW FOR VEERHEALTH CARE LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 47.41 Lk | 25.85 Lk | 1.05 Cr | 1.29 Cr |
| Adjustment | 37.25 Lk | 9.61 Lk | 53.08 Lk | 46.89 Lk |
| Changes In working Capital | 39.08 Lk | 1.49 Cr | -2.08 Cr | 1.42 Cr |
| Cash Flow after changes in Working Capital | 1.24 Cr | 1.85 Cr | -50.11 Lk | 3.18 Cr |
| Cash Flow from Operating Activities | 1 Cr | 1.81 Cr | -69.76 Lk | 2.9 Cr |
| Cash Flow from Investing Activities | -9.16 Lk | -1.09 Cr | -1.79 Cr | -27.51 Lk |
| Cash Flow from Financing Activitie | -82.69 Lk | -41.72 Lk | 5.69 Cr | -5.99 Cr |
| Net Cash Inflow / Outflow | 8.55 Lk | 30.21 Lk | 3.21 Cr | -3.37 Cr |
| Opening Cash & Cash Equivalents | 1.63 Lk | 10.18 Lk | 40.39 Lk | 3.61 Cr |
| Closing Cash & Cash Equivalent | 10.18 Lk | 40.39 Lk | 3.61 Cr | 23.85 Lk |
STANDALONE CASH FLOW FOR VEERHEALTH CARE LIMITED
| Year End | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| No of Months | 12 months | 12 months | 12 months | 12 months |
| Profit Before Tax | 47.41 Lk | 25.85 Lk | 1.05 Cr | 1.29 Cr |
| Adjustment | 37.25 Lk | 9.61 Lk | 53.08 Lk | 46.89 Lk |
| Changes In working Capital | 39.08 Lk | 1.49 Cr | -2.08 Cr | 1.42 Cr |
| Cash Flow after changes in Working Capital | 1.24 Cr | 1.85 Cr | -50.11 Lk | 3.18 Cr |
| Cash Flow from Operating Activities | 1 Cr | 1.81 Cr | -69.76 Lk | 2.9 Cr |
| Cash Flow from Investing Activities | -9.16 Lk | -1.09 Cr | -1.79 Cr | -27.51 Lk |
| Cash Flow from Financing Activitie | -82.69 Lk | -41.72 Lk | 5.69 Cr | -5.99 Cr |
| Net Cash Inflow / Outflow | 8.55 Lk | 30.21 Lk | 3.21 Cr | -3.37 Cr |
| Opening Cash & Cash Equivalents | 1.63 Lk | 10.18 Lk | 40.39 Lk | 3.61 Cr |
| Closing Cash & Cash Equivalent | 10.18 Lk | 40.39 Lk | 3.61 Cr | 23.85 Lk |
CONSOLIDATED BALANCE SHEET FOR VEERHEALTH CARE LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 6.93 Cr | 6.93 Cr | 10 Cr | 20 Cr |
| Equity - Authorised | 10 Cr | 10 Cr | 20 Cr | 31 Cr |
| Equity - Issued | 6.93 Cr | 6.93 Cr | 10 Cr | 20 Cr |
| Equity Paid Up | 6.93 Cr | 6.93 Cr | 10 Cr | 20 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | 7.11 Cr | 7.02 Cr | 11.43 Cr | 1.84 Cr |
| Securities Premium | 5.84 Cr | 5.84 Cr | 8.67 Cr | 0 |
| Profit & Loss Account Balance | 58.42 Lk | 43.19 Lk | 1.95 Cr | 1.04 Cr |
| General Reserves | 73.06 Lk | 73.06 Lk | 73.06 Lk | 73.06 Lk |
| Reserve excluding Revaluation Reserve | 7.11 Cr | 7.02 Cr | 11.43 Cr | 1.84 Cr |
| Shareholder's Funds | 14.04 Cr | 13.95 Cr | 21.43 Cr | 21.84 Cr |
| Secured Loans | 1.41 Cr | 0 | 0 | 0 |
| Term Loans - Institutions | 1.41 Cr | 0 | 0 | 0 |
| Deferred Tax Assets / Liabilities | 51.27 Lk | 80.73 Lk | 14.57 Lk | 73.61 Lk |
| Deferred Tax Assets | 5.1 Lk | 4.88 Lk | 6.6 Lk | 4.96 Lk |
| Deferred Tax Liability | 56.37 Lk | 85.61 Lk | 21.17 Lk | 78.57 Lk |
| Other Long Term Liabilities | 1.02 Cr | 2.76 Cr | 2.56 Cr | 2.39 Cr |
| Long Term Trade Payables | 0 | 1.37 Lk | 2.08 Lk | 0 |
| Long Term Provisions | 16.04 Lk | 15.79 Lk | 12.6 Lk | 37.77 Lk |
| Total Non-Current Liabilities | 3.11 Cr | 3.74 Cr | 2.85 Cr | 3.5 Cr |
| Trade Payables | 91.66 Lk | 2.32 Cr | 55.43 Lk | 2.16 Cr |
| Sundry Creditors | 91.66 Lk | 2.32 Cr | 55.43 Lk | 2.16 Cr |
| Other Current Liabilities | 5.44 Lk | 10.67 Lk | 16.86 Lk | 28.58 Lk |
| Advances received from customers | 4.08 Lk | 4.15 Lk | 6.62 Lk | 9.49 Lk |
| Short Term Borrowings | 32.02 Lk | 0 | 0 | 0 |
| Secured ST Loans repayable on Demands | 32.02 Lk | 0 | 0 | 0 |
| Working Capital Loans- Sec | 62,000 | 0 | 0 | 0 |
| Short Term Provisions | 28.56 Lk | 3.75 Lk | 25.16 Lk | 33.21 Lk |
| Provision for Tax | 24.19 Lk | 3.75 Lk | 23.4 Lk | 28.5 Lk |
| Total Current Liabilities | 1.58 Cr | 2.46 Cr | 97.45 Lk | 2.77 Cr |
| Total Liabilities | 18.73 Cr | 20.15 Cr | 25.25 Cr | 28.12 Cr |
| Gross Block | 11.37 Cr | 12.96 Cr | 15.05 Cr | 16.03 Cr |
| Less: Accumulated Depreciation | 1.89 Cr | 2.42 Cr | 3.04 Cr | 4.06 Cr |
| Net Block | 9.48 Cr | 10.54 Cr | 12.01 Cr | 11.97 Cr |
| Long Term Loans & Advances | 2.41 Cr | 3.38 Cr | 2.9 Cr | 2.69 Cr |
| Total Non-Current Assets | 11.89 Cr | 13.92 Cr | 14.91 Cr | 14.66 Cr |
| Inventories | 1.66 Cr | 2.12 Cr | 2.61 Cr | 1.4 Cr |
| Sundry Debtors | 1.54 Cr | 1.54 Cr | 1.84 Cr | 3.92 Cr |
| Debtors more than Six months | 0 | 34,000 | 0 | 25.48 Lk |
| Debtors Others | 1.54 Cr | 1.54 Cr | 1.84 Cr | 3.67 Cr |
| Cash and Bank | 10.18 Lk | 40.39 Lk | 3.61 Cr | 23.85 Lk |
| Cash in hand | 1.01 Lk | 4.23 Lk | 4.49 Lk | 2.14 Lk |
| Balances at Bank | 9.17 Lk | 36.16 Lk | 3.57 Cr | 21.71 Lk |
| Short Term Loans and Advances | 3.53 Cr | 2.16 Cr | 2.29 Cr | 7.9 Cr |
| Advances recoverable in cash or in kind | 2.6 Lk | 6.89 Lk | 18.74 Lk | 2.44 Lk |
| Total Current Assets | 6.84 Cr | 6.23 Cr | 10.34 Cr | 13.46 Cr |
| Net Current Assets (Including Current Investments) | 5.26 Cr | 3.77 Cr | 9.37 Cr | 10.68 Cr |
| Total Assets | 18.73 Cr | 20.15 Cr | 25.25 Cr | 28.12 Cr |
| Total Debt | 1.73 Cr | 0 | 0 | 0 |
| Book Value | 20.25 | 20.12 | 21.43 | 0 |
| Adjusted Book Value | 20.25 | 20.12 | 21.43 | 10.92 |
STANDALONE BALANCE SHEET FOR VEERHEALTH CARE LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Share Capital | 6.93 Cr | 6.93 Cr | 10 Cr | 20 Cr |
| Equity - Authorised | 10 Cr | 10 Cr | 20 Cr | 31 Cr |
| Equity - Issued | 6.93 Cr | 6.93 Cr | 10 Cr | 20 Cr |
| Equity Paid Up | 6.93 Cr | 6.93 Cr | 10 Cr | 20 Cr |
| Face Value | 10 | 10 | 10 | 10 |
| Total Reserves | 7.11 Cr | 7.02 Cr | 11.43 Cr | 1.84 Cr |
| Securities Premium | 5.84 Cr | 5.84 Cr | 8.67 Cr | 0 |
| Profit & Loss Account Balance | 58.42 Lk | 43.19 Lk | 1.95 Cr | 1.04 Cr |
| General Reserves | 73.06 Lk | 73.06 Lk | 73.06 Lk | 73.06 Lk |
| Reserve excluding Revaluation Reserve | 7.11 Cr | 7.02 Cr | 11.43 Cr | 1.84 Cr |
| Shareholder's Funds | 14.04 Cr | 13.95 Cr | 21.43 Cr | 21.84 Cr |
| Secured Loans | 1.41 Cr | 0 | 0 | 0 |
| Term Loans - Institutions | 1.41 Cr | 0 | 0 | 0 |
| Deferred Tax Assets / Liabilities | 51.27 Lk | 80.73 Lk | 14.57 Lk | 73.61 Lk |
| Deferred Tax Assets | 5.1 Lk | 4.88 Lk | 6.6 Lk | 4.96 Lk |
| Deferred Tax Liability | 56.37 Lk | 85.61 Lk | 21.17 Lk | 78.57 Lk |
| Other Long Term Liabilities | 1.02 Cr | 2.76 Cr | 2.56 Cr | 2.39 Cr |
| Long Term Trade Payables | 0 | 1.37 Lk | 2.08 Lk | 0 |
| Long Term Provisions | 16.04 Lk | 15.79 Lk | 12.6 Lk | 37.77 Lk |
| Total Non-Current Liabilities | 3.11 Cr | 3.74 Cr | 2.85 Cr | 3.5 Cr |
| Trade Payables | 91.66 Lk | 2.32 Cr | 55.43 Lk | 2.16 Cr |
| Sundry Creditors | 91.66 Lk | 2.32 Cr | 55.43 Lk | 2.16 Cr |
| Other Current Liabilities | 5.44 Lk | 10.67 Lk | 16.86 Lk | 28.58 Lk |
| Advances received from customers | 4.08 Lk | 4.15 Lk | 6.62 Lk | 9.49 Lk |
| Short Term Borrowings | 32.02 Lk | 0 | 0 | 0 |
| Secured ST Loans repayable on Demands | 32.02 Lk | 0 | 0 | 0 |
| Working Capital Loans- Sec | 62,000 | 0 | 0 | 0 |
| Short Term Provisions | 28.56 Lk | 3.75 Lk | 25.16 Lk | 33.21 Lk |
| Provision for Tax | 24.19 Lk | 3.75 Lk | 23.4 Lk | 28.5 Lk |
| Total Current Liabilities | 1.58 Cr | 2.46 Cr | 97.45 Lk | 2.77 Cr |
| Total Liabilities | 18.73 Cr | 20.15 Cr | 25.25 Cr | 28.12 Cr |
| Gross Block | 11.37 Cr | 12.96 Cr | 15.05 Cr | 16.03 Cr |
| Less: Accumulated Depreciation | 1.89 Cr | 2.42 Cr | 3.04 Cr | 4.06 Cr |
| Net Block | 9.48 Cr | 10.54 Cr | 12.01 Cr | 11.97 Cr |
| Long Term Loans & Advances | 2.41 Cr | 3.38 Cr | 2.9 Cr | 2.69 Cr |
| Total Non-Current Assets | 11.89 Cr | 13.92 Cr | 14.91 Cr | 14.66 Cr |
| Inventories | 1.66 Cr | 2.12 Cr | 2.61 Cr | 1.4 Cr |
| Sundry Debtors | 1.54 Cr | 1.54 Cr | 1.84 Cr | 3.92 Cr |
| Debtors more than Six months | 0 | 34,000 | 0 | 25.48 Lk |
| Debtors Others | 1.54 Cr | 1.54 Cr | 1.84 Cr | 3.67 Cr |
| Cash and Bank | 10.18 Lk | 40.39 Lk | 3.61 Cr | 23.85 Lk |
| Cash in hand | 1.01 Lk | 4.23 Lk | 4.49 Lk | 2.14 Lk |
| Balances at Bank | 9.17 Lk | 36.16 Lk | 3.57 Cr | 21.71 Lk |
| Short Term Loans and Advances | 3.53 Cr | 2.16 Cr | 2.29 Cr | 7.9 Cr |
| Advances recoverable in cash or in kind | 2.6 Lk | 6.89 Lk | 18.74 Lk | 2.44 Lk |
| Total Current Assets | 6.84 Cr | 6.23 Cr | 10.34 Cr | 13.46 Cr |
| Net Current Assets (Including Current Investments) | 5.26 Cr | 3.77 Cr | 9.37 Cr | 10.68 Cr |
| Total Assets | 18.73 Cr | 20.15 Cr | 25.25 Cr | 28.12 Cr |
| Total Debt | 1.73 Cr | 0 | 0 | 0 |
| Book Value | 20.25 | 20.12 | 21.43 | 0 |
| Adjusted Book Value | 20.25 | 20.12 | 21.43 | 10.92 |
FINANCIAL RATIOS (CONSOLIDATED) FOR VEERHEALTH CARE LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 0.55 | -0.11 | 1.58 | 0.2 |
| CEPS(Rs) | 1.22 | 0.65 | 2.2 | 0.56 |
| Book NAV/Share(Rs) | 20.25 | 20.12 | 21.43 | 10.92 |
| Tax Rate(%) | 34.24 | 130.98 | -41.64 | 68.31 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | -0.59 | -8.62 | 3.7 | 4.62 |
| EBIT Margin(%) | 7.52 | 3.35 | 8.42 | 9.75 |
| Pre Tax Margin(%) | 5.45 | 2.47 | 8.41 | 9.69 |
| PAT Margin (%) | 3.58 | -0.76 | 11.92 | 3.07 |
| Cash Profit Margin (%) | 8.01 | 4.68 | 16.6 | 8.45 |
| Performance Ratios | ||||
| ROA(%) | 2.07 | -0.38 | 6.97 | 1.52 |
| ROE(%) | 2.73 | -0.53 | 8.94 | 1.88 |
| ROCE(%) | 4.97 | 2.17 | 6.32 | 5.96 |
| Asset Turnover(x) | 0.58 | 0.5 | 0.58 | 0.5 |
| Sales/Fixed Asset(x) | 0.95 | 0.79 | 0.95 | 0.85 |
| Working Capital/Sales(x) | 2.01 | 2.56 | 1.42 | 1.24 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 1.05 | 1.26 | 1.05 | 1.18 |
| Receivable days | 42.78 | 58.5 | 46.47 | 79.49 |
| Inventory Days | 49.91 | 71.8 | 65.03 | 55.23 |
| Payable days | 42.57 | 85.29 | 56.81 | 54.17 |
| Valuation Parameters | ||||
| PER(x) | 13.9 | 0 | 12.67 | 102.17 |
| PCE(x) | 6.22 | 17.59 | 9.1 | 37.13 |
| Price/Book(x) | 0.38 | 0.57 | 0.94 | 1.9 |
| EV/Net Sales(x) | 0.65 | 0.78 | 1.24 | 3.12 |
| EV/Core EBITDA(x) | 5.46 | 8.88 | 9.45 | 20.62 |
| EV/EBIT(x) | 8.68 | 23.31 | 14.7 | 32.01 |
| EV/CE(x) | 0.37 | 0.37 | 0.65 | 1.89 |
| M Cap / Sales | 0.5 | 0.82 | 1.51 | 3.14 |
| Growth Ratio | ||||
| Net Sales Growth(%) | -9.79 | -9.01 | 37.89 | -0.38 |
| Core EBITDA Growth(%) | 8.87 | -32.97 | 105.46 | 14.97 |
| EBIT Growth(%) | -5.03 | -59.42 | 246.51 | 15.27 |
| PAT Growth(%) | 19.13 | -119.41 | 2249.46 | -74.33 |
| EPS Growth(%) | 19.15 | -119.41 | 1590.57 | -87.16 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.12 | 0 | 0 | 0 |
| Current Ratio(x) | 4.34 | 2.53 | 10.61 | 4.85 |
| Quick Ratio(x) | 3.28 | 1.67 | 7.94 | 4.35 |
| Interest Cover(x) | 3.64 | 3.79 | 860.15 | 169.61 |
| Total Debt/Mcap(x) | 0.33 | 0 | 0 | 0 |
FINANCIAL RATIOS (STANDALONE) FOR VEERHEALTH CARE LIMITED
| YEAR | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
|---|---|---|---|---|
| Operational & Financial Ratios | ||||
| Earnings Per Share (Rs) | 0.55 | -0.11 | 1.58 | 0.2 |
| CEPS(Rs) | 1.22 | 0.65 | 2.2 | 0.56 |
| Book NAV/Share(Rs) | 20.25 | 20.12 | 21.43 | 10.92 |
| Tax Rate(%) | 34.24 | 130.98 | -41.64 | 68.31 |
| Margin Ratios | ||||
| Core EBITDA Margin(%) | -0.59 | -8.62 | 3.7 | 4.62 |
| EBIT Margin(%) | 7.52 | 3.35 | 8.42 | 9.75 |
| Pre Tax Margin(%) | 5.45 | 2.47 | 8.41 | 9.69 |
| PAT Margin (%) | 3.58 | -0.76 | 11.92 | 3.07 |
| Cash Profit Margin (%) | 8.01 | 4.68 | 16.6 | 8.45 |
| Performance Ratios | ||||
| ROA(%) | 2.07 | -0.38 | 6.97 | 1.52 |
| ROE(%) | 2.73 | -0.53 | 8.94 | 1.88 |
| ROCE(%) | 4.97 | 2.17 | 6.32 | 5.96 |
| Asset Turnover(x) | 0.58 | 0.5 | 0.58 | 0.5 |
| Sales/Fixed Asset(x) | 0.95 | 0.79 | 0.95 | 0.85 |
| Working Capital/Sales(x) | 2.01 | 2.56 | 1.42 | 1.24 |
| Efficiency Ratios | ||||
| Fixed Capital/Sales(x) | 1.05 | 1.26 | 1.05 | 1.18 |
| Receivable days | 42.78 | 58.5 | 46.47 | 79.49 |
| Inventory Days | 49.91 | 71.8 | 65.03 | 55.23 |
| Payable days | 42.57 | 85.29 | 56.81 | 54.17 |
| Valuation Parameters | ||||
| PER(x) | 13.9 | 0 | 12.67 | 102.17 |
| PCE(x) | 6.22 | 17.59 | 9.1 | 37.13 |
| Price/Book(x) | 0.38 | 0.57 | 0.94 | 1.9 |
| EV/Net Sales(x) | 0.65 | 0.78 | 1.24 | 3.12 |
| EV/Core EBITDA(x) | 5.46 | 8.88 | 9.45 | 20.62 |
| EV/EBIT(x) | 8.68 | 23.31 | 14.7 | 32.01 |
| EV/CE(x) | 0.37 | 0.37 | 0.65 | 1.89 |
| M Cap / Sales | 0.5 | 0.82 | 1.51 | 3.14 |
| Growth Ratio | ||||
| Net Sales Growth(%) | -9.79 | -9.01 | 37.89 | -0.38 |
| Core EBITDA Growth(%) | 8.87 | -32.97 | 105.46 | 14.97 |
| EBIT Growth(%) | -5.03 | -59.42 | 246.51 | 15.27 |
| PAT Growth(%) | 19.13 | -119.41 | 2249.46 | -74.33 |
| EPS Growth(%) | 19.15 | -119.41 | 1590.57 | -87.16 |
| Financial Stability Ratios | ||||
| Total Debt/Equity(x) | 0.12 | 0 | 0 | 0 |
| Current Ratio(x) | 4.34 | 2.53 | 10.61 | 4.85 |
| Quick Ratio(x) | 3.28 | 1.67 | 7.94 | 4.35 |
| Interest Cover(x) | 3.64 | 3.79 | 860.15 | 169.61 |
| Total Debt/Mcap(x) | 0.33 | 0 | 0 | 0 |
SHARE HOLDING PATTERN FOR VEERHEALTH CARE LIMITED
| Date | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoters % | 44.31 | 44.36 | 44.36 | 30.76 | 30.76 | 30.76 | 30.76 | 30.41 | 30.41 | 30.41 |
| FII % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| DII % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public % | 55.69 | 55.64 | 55.64 | 69.24 | 69.24 | 69.24 | 69.24 | 69.59 | 69.59 | 69.59 |
PEER COMPARISON FOR VEERHEALTH CARE LIMITED
CORPORATE ACTIONS FOR VEERHEALTH CARE
| Exchange Date | Purpose | Book Closure Dates |
|---|---|---|
| BSE 29-Aug-2024 | Book Closure - A.G.M. | 24-Sep-2024 30-Sep-2024 |
| BSE 29-Aug-2024 | AGM - A.G.M. | 30-Sep-2024 30-Sep-2024 |
| BSE 06-Aug-2024 | Board Meeting - Quarterly Results & Increase in Authorised Capital | 14-Aug-2024 |
| BSE 21-May-2024 | Board Meeting - Final Dividend & Audited Results | 30-May-2024 |
| BSE 20-Feb-2024 | Rights issue - Right Issue of Equity Shares | |
| BSE 15-Feb-2024 | Board Meeting - Inter alia, to consider, Examine, evaluate various options to raise funds by issue of Preference / Right shares along with Banking Loan for expansion. | 20-Feb-2024 |
| BSE 02-Feb-2024 | Board Meeting - Quarterly Results & Inter alia, to consider and approve:- Company is planning to do expansion and to meet up those Capital Expenditure, to consider capital raising options for the Company, as the Board may deem appropriate. | 10-Feb-2024 |
| BSE 30-Oct-2023 | Board Meeting - Quarterly Results | 08-Nov-2023 |
| BSE 14-Sep-2023 | Board Meeting - Bonus issue | 25-Sep-2023 |
| BSE 16-Aug-2023 | Book Closure - A.G.M. | 05-Sep-2023 11-Sep-2023 |
| BSE 16-Aug-2023 | AGM - A.G.M. | 11-Sep-2023 11-Sep-2023 |
| BSE 04-Aug-2023 | Board Meeting - Quarterly Results & Increase in Authorised Capital & Bonus issue & A.G.M. | 14-Aug-2023 |
| BSE 04-Aug-2023 | Bonus issue - Quarterly Results & Increase in Authorised Capital & Bonus issue & A.G.M. | 14-Aug-2023 |
| BSE 15-May-2023 | Board Meeting - Dividend & Audited Results | 22-May-2023 |
| BSE 06-Mar-2023 | Board Meeting - Preferential Issue of shares | 10-Mar-2023 |
| BSE 06-Feb-2023 | Board Meeting - Quarterly Results | 13-Feb-2023 |
| BSE 28-Nov-2022 | Board Meeting - Inter alia, consider and approve: 1. Notice of Extra Ordinary General Meeting (EGM) for Preferential issue of shares; 2. Appointment of Scrutinizer for EGM; 3. Any other matters with the permission of chair; | 05-Dec-2022 |
| BSE 14-Nov-2022 | Board Meeting - Preferential Issue of shares | 23-Nov-2022 |
| BSE 01-Nov-2022 | Board Meeting - Quarterly Results | 10-Nov-2022 |
| BSE 16-Aug-2022 | Book Closure - A.G.M. | 24-Sep-2022 30-Sep-2022 |
| BSE 16-Aug-2022 | AGM - A.G.M. | 30-Sep-2022 30-Sep-2022 |
| BSE 04-Aug-2022 | Board Meeting - Quarterly Results & A.G.M. | 12-Aug-2022 |
| BSE 20-May-2022 | Board Meeting - Audited Results | 30-May-2022 |
| BSE 21-Mar-2022 | Delist - Dear Sir, This is to inform that Company has received approval for voluntary delisting of Equity Shares from Metropolitan Stock Exchange of India Limited. We are attaching herewith the approval letter received from Metropolitan Stock Exchange of India Limited. The shares of the Company will continue to remain listed on BSE Limited. This is for your information and records. | |
| BSE 11-Feb-2022 | Delist - The Board has considered and preliminary approved to voluntarily delisting of Equity Sh ares of the Company from Metropolitan Stock Exchange of India Limited pursuant to the provisions of Regulation 5 and 6 of the SEBI (Delisting of Equity Shares) Regulations, 2021. The shares of the Company will continue to remain listed on BSE Limited. | 11-Feb-2022 |
| BSE 03-Feb-2022 | Delist - Voluntary Delisting of Shares & Quarterly Results | 11-Feb-2022 |
| BSE 03-Feb-2022 | Board Meeting - Voluntary Delisting of Shares & Quarterly Results | 11-Feb-2022 |
| BSE 01-Nov-2021 | Board Meeting - Quarterly Results | 12-Nov-2021 |
CORPORATE ANNOUNCEMENTS FOR VEERHEALTH CARE
| Exchange Date | Category File | Description |
|---|---|---|
| BSE 07-Oct-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Pursuant to Regulation Regulation 74(5) of the SEBI (DP) Regulations 2018 we are hereby submitting the certificate received from M/s. Purva Sharegistry (India) Pvt. Ltd. the Registrar and Share Transfer Agent of the Company for the quarter ended 30th September 2024. |
| BSE 01-Oct-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Scrutinizer''s Report In terms of Regulation 44(3) of SEBI (LODR) Regulations 2015 please find enclosed herewith the consolidated Report of the Scrutinizer of e-voting and voting at the 32nd Annual General Meeting of the Company. |
| BSE 30-Sep-2024 | Outcome FILE | Shareholder Meeting / Postal Ballot-Outcome of AGM Please find attached herewith the Outcome of the Annual General Meeting of the Company held today i.e. on Monday 30th September 2024. |
| BSE 26-Sep-2024 | Intimation FILE | Closure of Trading Window Intimation of Closure of Trading Window. |
| BSE 18-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Investor Presentation Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 please find enclosed Investors Presentation of the Company. |
| BSE 13-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release Veerhealth Care Limited is proud to announce that the Company has received further Export Order worth US$ 40111 (Rs. 0.34 Crore Approx.) from existing top institutional supplier Company in United States of America.Please find enclosed herewith a copy of Press Release giving information about the same. |
| BSE 12-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order Receipt of further Export Order from existing USA customer |
| BSE 03-Sep-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Newspaper Publication Please find enclosed herewith the Newspaper Advertisement published on 3rd September 2024 regarding Notice of 32nd Annual General Meeting Book Closure and E-Voting. |
| BSE 26-Aug-2024 | Intimation FILE | Book Closure For The Purpose Of 32Nd Annual General Meeting Of The Company. This is to inform that Register of Members and Share Transfer Books of the Company will remain closed from 24th September 2024 to 30th September 2024 (both days inclusive) for the purpose of 32nd Annual General Meeting of the Company to be held on 30th September 2024. |
| BSE 26-Aug-2024 | General Announcements FILE | Reg. 34 (1) Annual Report. Pursuant to Regulation 34(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith the Annual Report for the financial year 2023-24. The same will be made available on the website of the Company at www.veerhealthcare.net. |
| BSE 26-Aug-2024 | Intimation FILE | Shareholder Meeting - AGM On September 30 2024 Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 we enclose herewith the Notice of the 32nd Annual General Meeting of the Company along with Annual Report for the financial year 2023-24. The same will be made available on the website of the Company at www.veerhealthcare.net. |
| BSE 14-Aug-2024 | General Announcements FILE | Announcement Under Regulation 30 (LODR) - Reappointment Of Managing Director And Executive Director Of The Company Please find enclosed Intimation under Regulation 30 of SEBI (LODR) for Reappointment of Managing Director and Executive Director of the Company. |
| BSE 14-Aug-2024 | Outcome FILE | Results-Financial Results For June 30 2024 Please find enclosed Unaudited Financial Results along with Limited Review Report for the quarter ended June 30 2024. |
| BSE 14-Aug-2024 | Outcome FILE | Board Meeting Outcome for Outcome Of Board Meeting Please find enclosed Outcome of Board Meeting held on 14th August 2024. |
| BSE 13-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release Veerhealth Care Limited is proud to announce that the Company has received further export order worth US$ 101680 (Rs. 84 Lakhs Approx.) which contains order of new toothpaste variant. Please find enclosed herewith a copy of Press Release giving information about the same. |
| BSE 12-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order Receipt of further export order of new variant from existing USA customer. |
| BSE 08-Aug-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release Veerhealth Care Limited is pleased to announce its expansion plans and new production capabilities. Please find enclosed herewith a copy of Press Release giving information about the same. |
| BSE 06-Aug-2024 | General Announcements FILE | Announcement Under Regulation 30 (LODR) - Facility Expansion And New Production Capabilities Please find enclosed herewith the details regarding facility expansion and new production capabilities of the Company. |
| BSE 06-Aug-2024 | Intimation FILE | Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results Of The Company For The Quarter Ended 30Th June 2024. Veerhealth Care Limitedhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve 1. Unaudited financial results of the Company for the quarter ended 30th June 2024.2. To increase Authorized Share Capital of the Company.3. Re-appointment of Mr. Bhavin Shah as Managing Director of the Company subject to approval of shareholders of the Company.4. Re-appointment of Mrs. Shruti Shah as Executive Director of the Company subject to approval of shareholders of the Company.5. Draft Directors Report for the financial year ending 31st March 2024.6. Draft notice convening 32nd Annual General Meeting of the Company.7. To fix Book Closure date.8. To appoint a Director in place of Mrs. Shruti Shah who retires by rotation. |
| BSE 22-Jul-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release Veerhealth Care Limited is pleased to announce that the Company has received a repeat order in hair care category from one of the leading corporate healthcare company which is already an existing client. Please find enclosed herewith a copy of Press Release giving information about the same. |
| BSE 22-Jul-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order Receipt of repeat Order from existing client. |
| BSE 13-Jul-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Press Release / Media Release Veerhealth Care Limited is pleased to announce that the Company have received new export order worth US $ 106673 from existing top institutional supplier Company in the United States of America. Please find enclosed a copy of Press Release giving information about the same. |
| BSE 11-Jul-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order Receipt of further Export Order from existing USA customer. |
| BSE 10-Jul-2024 | General Announcements FILE | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Pursuant to Regulation 74(5) of SEBI (DP) Regulations 2018 we are hereby submitting the certificate received from M/s. Purva Sharegistry (India) Pvt. Ltd. the Registrar and Share Transfer Agent of the Company for the quarter ended 30th June 2024. |
| BSE 26-Jun-2024 | Intimation FILE | Closure of Trading Window Intimation of Closure of Trading Window |
| BSE 26-Jun-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Investor Presentation Pursuant to Regulation 30 of the SEBI (LODR) Regulations 2015 please find enclosed Investors Presentation on the Audited Financial Results for the quarter and year ended 31st March 2024. |
| BSE 19-Jun-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Earnings Call Transcript In continuation of the letter dated June 08 2024 related to the Investor Conference Call to discuss the Financial Results for the Quarter ended March 31 2024 and pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find attached the Transcripts of the Companys Investor Call. |
| BSE 14-Jun-2024 | General Announcements FILE | 'Ayuveer' Products Now Available On Nykaa For Purchase We are delighted to announce that our brand Ayuveers products have successfully completed the onboarding process on Nykaas mobile application and website. |
| BSE 12-Jun-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome With reference to our letter dated June 08 2024 related to the Investor Conference Call and pursuant to Regulations 30 and 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended and Guidance note issued by the Stock Exchange dated July 29 2022 we hereby inform you that the audio call recording of the Companys Investor Call to discuss the Financial Results for the Quarter ended March 31 2024 is available on the website of the Company www.veerhealthcare.net.The link to access the said audio recording is:https://veerhealthcare.net/wp-content/uploads/2024/06/Earning-Concall-Audio-of-Veerhealth-Care-Limited-Q4-FY24.mp3Mr. Bhavin Shah Managing Director and Mr. Akash Shah Chief Financial Officer were the Management attendees.It is further confirmed that no unpublished price sensitive information was shared/discussed in the meeting / call. |
| BSE 08-Jun-2024 | General Announcements FILE | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform that the Management team of the Company shall be participating in Q4 FY23-24 earnings call scheduled on Wednesday June 12 2024 at 2.00 pm (IST) hosted by Kirin Advisors.Please find attached details of the invitation. |
INSIDER TRADING FOR VEERHEALTH CARE
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 21-Mar-2024 21-Mar-2024 | Buy Market | 85,000 @ 0.00 (0.43 %) | Yogesh Mahasuklal Shah |
| BSE 13-Mar-2024 13-Mar-2024 | Buy Market | 100,000 @ 0.00 (0.50 %) | Yogesh Mahasuklal Shah |
| BSE 12-Mar-2024 12-Mar-2024 | Buy Market | 150,000 @ 0.00 (0.75 %) | Yogesh Mahasuklal Shah |
| BSE 06-Mar-2024 06-Mar-2024 | Buy Market | 100,000 @ 0.00 (0.50 %) | Mahasuklal Shah HUF |
| BSE 05-Mar-2024 05-Mar-2024 | Buy Market | 100,000 @ 0.00 (0.00 %) | Mahasuklal Shah HUF |
| BSE 23-Feb-2024 23-Feb-2024 | Sell Market | 500,000 @ 0.00 (2.50 %) | Krupa Harsh Jain |
BULK BLOCK DEALS FOR VEERHEALTH CARE LIMITED
| Exchange Dates | Activity | Qty & Price (%) | Person / Organisation |
|---|---|---|---|
| BSE 16-Sep-2024 | Sell BULK | 127,473 @ 24.52 | SIDHESHBHAI DEVABHAI RAVAL |
| BSE 16-Sep-2024 | Buy BULK | 127,473 @ 24.00 | SIDHESHBHAI DEVABHAI RAVAL |
| BSE 16-Sep-2024 | Sell BULK | 117,988 @ 24.00 | JAYAKRISHNA TAPARIA |
| BSE 12-Sep-2024 | Buy BULK | 158,105 @ 23.63 | VIKRAMKUMAR KARANRAJ SAKARIA HUF |
| BSE 12-Sep-2024 | Sell BULK | 158,105 @ 23.97 | VIKRAMKUMAR KARANRAJ SAKARIA HUF |
| BSE 12-Sep-2024 | Sell BULK | 103,278 @ 23.73 | SHALIN MAHESHBHAI SHAH |
| BSE 12-Sep-2024 | Buy BULK | 103,278 @ 23.98 | SHALIN MAHESHBHAI SHAH |
| BSE 09-Aug-2024 | Buy BULK | 100,000 @ 23.47 | VENKATESH PRASHANTH |
| BSE 01-Aug-2024 | Buy BULK | 101,900 @ 24.29 | RAHUL YASHVANTRAY SHAH |
| BSE 22-Jul-2024 | Sell BULK | 140,134 @ 24.85 | RAHUL YASHVANTRAY SHAH |
| BSE 22-Jul-2024 | Buy BULK | 24,000 @ 24.75 | RAHUL YASHVANTRAY SHAH |
| BSE 19-Jul-2024 | Buy BULK | 161,857 @ 24.23 | RAHUL YASHVANTRAY SHAH |
| BSE 19-Jul-2024 | Sell BULK | 20,923 @ 24.27 | RAHUL YASHVANTRAY SHAH |
| BSE 18-Jul-2024 | Buy BULK | 180,000 @ 24.25 | HARDIK INDRAMAL JAIN |
| BSE 16-Jul-2024 | Sell BULK | 100,000 @ 25.06 | ARYAMAN BHARAT TAPARIA |
| BSE 15-Jul-2024 | Buy BULK | 100,000 @ 23.67 | BHUMIKABEN PATEL |
| BSE 15-Jul-2024 | Buy BULK | 398,021 @ 24.07 | GAYATRIBEN NISHANT SHAH |
| BSE 15-Jul-2024 | Sell BULK | 413,505 @ 23.88 | GAYATRIBEN NISHANT SHAH |
| BSE 15-Jul-2024 | Sell BULK | 251,962 @ 24.05 | SHALIN MAHESHBHAI SHAH |
| BSE 12-Jul-2024 | Buy BULK | 107,618 @ 22.40 | GAYATRIBEN NISHANT SHAH |
| BSE 12-Jul-2024 | Sell BULK | 92,134 @ 22.23 | GAYATRIBEN NISHANT SHAH |
| BSE 12-Jul-2024 | Sell BULK | 142,701 @ 22.15 | SIDHESHBHAI DEVABHAI RAVAL |
| BSE 10-Jul-2024 | Sell BULK | 129,285 @ 21.95 | SHALIN MAHESHBHAI SHAH |
| BSE 08-Jul-2024 | Buy BULK | 100,000 @ 22.50 | GAYATRIBEN NISHANT SHAH |
| BSE 08-Jul-2024 | Sell BULK | 100,000 @ 21.47 | GAYATRIBEN NISHANT SHAH |
| BSE 08-Jul-2024 | Buy BULK | 388,758 @ 22.41 | SHALIN MAHESHBHAI SHAH |
| BSE 08-Jul-2024 | Sell BULK | 7,511 @ 21.47 | SHALIN MAHESHBHAI SHAH |
| BSE 08-Jul-2024 | Sell BULK | 507,410 @ 22.48 | SHUBHAM FINANCIAL SERVICES |
| BSE 08-Jul-2024 | Buy BULK | 186,584 @ 21.47 | SIDHESHBHAI DEVABHAI RAVAL |
| BSE 08-Jul-2024 | Sell BULK | 484 @ 21.48 | SIDHESHBHAI DEVABHAI RAVAL |
DIVIDEND BY VEERHEALTH CARE LIMITED
No dividend details found
SPLIT / BONUS BY VEERHEALTH CARE LIMITED
| Ex Date | Type | Detail |
|---|---|---|
| 22-Sep-2023 | BONUS | 1:1 |
Data feed Source : www.accordfintech.com, NSE DATA Feed & BSE Data Feed
